-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Enzon Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $49K, a 35.5% decline year-over-year.
- Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$195K, a 85.7% decline year-over-year.
- Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$156K, a 22% increase from 2022.
- Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$200K, a 2957% decline from 2021.
- Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $7K, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)